about
Carbamazepine for chronic neuropathic pain and fibromyalgia in adultsKetamine as an adjuvant to opioids for cancer painAntiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviewsAntiepileptic drugs for neuropathic pain and fibromyalgiaKetamine as an adjuvant to opioids for cancer painStructural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signalingPain- and morphine-associated transcriptional regulation of neuropeptide FF and the G-protein-coupled NPFF2 receptor geneThe effect of paracetamol and tropisetron on pain: experimental studies and a review of published data.Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review).A data science approach to candidate gene selection of pain regarded as a process of learning and neural plasticity.Aberrant temporal and spatial brain activity during rest in patients with chronic painOxycodone.Temperament traits and chronic pain: the association of harm avoidance and pain-related anxiety.Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.Profiles of pregabalin and gabapentin abuse by postmortem toxicology.Pharmacologic management of neuropathic pain: evidence-based recommendations.Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.Normal laser-evoked cortical responses in patients with chronic hemibody pain.Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsDiagnosing Depression in Chronic Pain Patients: DSM-IV Major Depressive Disorder vs. Beck Depression Inventory (BDI).Improving opioid effectiveness: from ideas to evidence.Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms.A systematic review of trial methodology, using the placebo groups of randomized controlled trials in paediatric postoperative pain.Cardiovascular and lifestyle risk factors in lumbar radicular pain or clinically defined sciatica: a systematic review.Development of a screening instrument for risk factors of persistent pain after breast cancer surgery.Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.Predictors of fibromyalgia: a population-based twin cohort studyControlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review.Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety.Effect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancerTransforming pain medicine: adapting to science and societyRisk factors of atherosclerosis and shoulder pain--is there an association? A systematic review.Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue.Recurrent lymphocytic meningitis positive for herpes simplex virus type 2.Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.Make a CHANGE: optimising communication and pain management decisions.Food, pain, and drugs: does it matter what pain patients eat?Does the pharmacology of oxycodone justify its increasing use as an analgesic?A holistic approach to chronic pain management that involves all stakeholders: change is needed.Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations.
P50
Q24197459-244C4B9E-B328-4903-B2EF-45761AC3C17CQ24197473-1A63807A-F8AE-414D-BAFC-4536AF4E0C18Q24202563-CB143DF2-AFA0-419E-BDC6-FE58589535C3Q24202629-F2640FE4-B0DE-436B-955F-84BA82477AEDQ24250218-76A2317A-014E-4C12-80A1-DF39A5DCADC7Q27303730-F2E10E5E-B748-421B-B9B2-02AD83A2E460Q28578163-A7B969EB-B113-4932-80FD-524D18A20187Q30558389-68516F16-9CAE-4981-883F-527140CA09EFQ30864797-08B51FC9-9885-4B94-8054-110BDD866E09Q31122869-891F7DEF-739A-4223-BF58-3CF66CCB54E5Q33778991-523A8A15-89D0-48F8-998A-E5EDA55C3BC3Q34420299-B04D9453-24A5-41DC-B2FE-F4D69B2966EEQ34469117-1AD4AB13-CD12-45B6-B200-896A132023F7Q34584569-8708630D-8E64-4643-B483-F17774ABF16AQ34661916-4A2BB3CC-51E2-4705-A3B8-5573E7E831E8Q34699259-6E90E134-025D-43E5-B34E-04DBA6D40CC1Q34742861-2B5F9E6A-0D81-4F0A-A1C4-C1FFC01BD2B2Q35530081-086B38AC-444F-4760-9ABF-420F9EF0AD7EQ35846608-4B76DFBF-6637-4878-AF2D-403E9E0054D4Q35967747-78F6F8E1-0404-4030-B0AB-AADC8A1258B3Q36057741-9C2F9D18-367D-4E31-B3AE-4BCFBE86D952Q36057778-217E2617-25C9-4636-BEA6-8929D0016552Q36152386-0747F377-D63A-4664-82A3-BA811035925CQ36274822-4E4C20E2-C187-4213-AB1B-39F38C431971Q36385344-185D6E01-29CC-4B64-BD19-E5AEB0386D06Q36459239-8BCE71BD-8EDB-4AF3-B487-019C064BB8F2Q36468997-587061DA-0105-4CB7-AAB8-6D6CF60D9662Q36480717-6FA2767C-FCEA-4796-8BB2-6588B00D0603Q36826970-7E44698F-3A44-4251-9483-ADDAC00855E2Q36906731-839E2C2B-8447-4B3E-9F7A-EF2D3545D0CFQ36926952-9D636092-050A-456F-A898-BFED4E6F9E9CQ36950658-B380D9EA-3C05-47F9-8652-894B924E885DQ36971659-102724A8-DE79-4338-A6BE-BB32415FECF7Q37347452-1436A871-BDC8-4169-8523-4F1A85E39B2AQ37595967-485D5629-E872-4A37-BB42-D46D518FE3BAQ37824874-7FBBD41C-8F6D-466F-9274-520B92EC1EFDQ38019228-05F1B28C-09EC-4ED8-BA17-66B006FBBA9BQ38086971-0D69C5D5-0825-4F65-B658-C07B13452E79Q38546843-617039FD-8FD4-4885-89F0-72656AFF7988Q38673453-AB017FDF-BB7D-42CC-B670-EC7427576C93
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eija Kalso
@ast
Eija Kalso
@en
Eija Kalso
@es
Eija Kalso
@fi
Eija Kalso
@nl
Eija Kalso
@sl
type
label
Eija Kalso
@ast
Eija Kalso
@en
Eija Kalso
@es
Eija Kalso
@fi
Eija Kalso
@nl
Eija Kalso
@sl
prefLabel
Eija Kalso
@ast
Eija Kalso
@en
Eija Kalso
@es
Eija Kalso
@fi
Eija Kalso
@nl
Eija Kalso
@sl
P106
P1280
P21
P31
P496
0000-0002-4899-605X
P569
2000-01-01T00:00:00Z